Verus Capital Partners’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$208K Sell
66,350
-2,000
-3% -$6.25K 0.01% 464
2026
Q1
$200K Sell
68,350
-3,650
-5% -$10.4K 0.01% 445
2025
Q4
$178K Buy
72,000
+30,000
+71% +$71.4K 0.01% 432
2025
Q3
$93.7K Buy
42,000
+7,000
+20% +$16K 0.01% 412
2025
Q2
$84.3K Sell
35,000
-5,000
-13% -$12.2K 0.01% 366
2025
Q1
$93.2K Buy
40,000
+5,000
+14% +$10K 0.01% 370
2024
Q4
$64.8K Buy
35,000
+5,800
+20% +$12.8K 0.01% 359
2024
Q3
$71.2K Sell
29,200
-3,000
-9% -$6.73K 0.01% 355
2024
Q2
$66K Buy
+32,200
New +$73.3K 0.01% 343
2020
Q1
$25K Sell
10,700
-1,200
-10% -$4.34K 0.01% 713
2019
Q4
$55K Buy
+11,900
New +$52.8K 0.02% 569

Other funds holding ABEV

Verus Capital Partners's ABEV Position: Q2 2026 in Review

Verus Capital Partners reduced its Ambev (ABEV) stake by 2.9% in Q2 2026, selling an estimated $6.25K and leaving 66,350 shares worth $208K. The position accounts for 0.01% of the portfolio, ranked #464.

Verus Capital Partners first reported a position in ABEV in Q4 2019 and has held it in 11 quarters since. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Verus Capital Partners held 66,350 shares of Ambev worth $208K as of Q2 2026.
  • Verus Capital Partners sold 2,000 Ambev shares in Q2 2026, an estimated $6.25K.
  • Ambev made up 0.01% of Verus Capital Partners's portfolio in Q2 2026, its #464 holding.
  • Verus Capital Partners first reported a position in Ambev in Q4 2019 and has held it in 11 quarters since.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Verus Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.